SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001461790-21-000070
Filing Date
2021-12-20
Accepted
2021-12-20 16:00:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G_KTTA_20211220.htm SC 13G 107093
  Complete submission text file 0001461790-21-000070.txt   108556
Mailing Address 2 BLOOR STREET WEST SUITE 801 TORONTO A6 M4W 3E2
Business Address 2 BLOOR STREET WEST SUITE 801 TORONTO A6 M4W 3E2 416-365-2155
K2 PRINCIPAL FUND, L.P. (Filed by) CIK: 0001461790 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Subject) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92867 | Film No.: 211505194
SIC: 2834 Pharmaceutical Preparations